Vivus

An 80% Plunge Leads the Biotech Bloodbath
Motley Fool
Tue, 09/25/12 - 12:41 pm
Peregrine Pharmaceuticals
Vertex Pharmaceuticals
Questcor
Arena Pharmaceuticals
Vivus
Obesity In America Likely To Set Up Arena And Vivus For Big Gains
TheStreet.com
Tue, 09/25/12 - 12:37 pm
Arena Pharmaceuticals
Vivus
obesity
Qsymia
Belviq
In The Wake Of An FDA Probe, It's Time Questcor Shareholders Begin To Consider Alternatives
Seeking Alpha
Mon, 09/24/12 - 06:03 pm
FDA
Questcor
Arena Pharmaceuticals
Merck
Pfizer
Vivus
Athcar
Vivus Plunges on European Setback; Analysts React
Barron's
Sat, 09/22/12 - 02:18 pm
Vivus
Qsymia
EU Approval? Fat Chance!
Motley Fool
Sat, 09/22/12 - 02:15 pm
Vivus
obesity
weight loss
Qsymia
Vivus Shares Feel The Pain: Blockbuster Diet Drug Likely Won't Be Sold In Europe
Forbes
Fri, 09/21/12 - 01:00 pm
Vivus
Europe
Qsiva
Qsymia
obesity
2 Big Events For Obesity Drugmakers
Motley Fool
Thu, 09/20/12 - 11:10 am
obesity
Arena Pharmaceuticals
Vivus
Qsymia
Belviq
[video] Fatter Profits for Drug Makers Ahead?
CNBC
Tue, 09/18/12 - 04:43 pm
obesity
Arena Pharmaceuticals
Orexigen
Vivus
Vivus Launches Qsymia - What To Look For Now
Seeking Alpha
Tue, 09/18/12 - 11:28 am
Vivus
Qsymia
Arena Pharmaceuticals
Eisai
Vivus Quietly Notes In 8-k That Qsymia Is Now Commercially Available
Yahoo/Reuters
Mon, 09/17/12 - 10:13 am
Qsymia
obesity
Vivus
Topiramate
J&J
Another Weight Loss Drug Gets Props from Wall Street
Wall Street Cheat Street
Sun, 09/9/12 - 11:04 am
Orexigen
Vivus
Arena Pharmaceuticals
Contrave
Belviq
Qsymia
weight loss
obesity
Vivus, Arena: Don't Be Too Late To The Punch Bowl, Buy Other Stocks
Seeking Alpha
Sat, 09/8/12 - 10:55 am
Vivus
Arena Pharmaceuticals
Pfizer
Neuralstem
Geron
Vivus' 60 Critical Minutes That Could Double Qsymia's Addressable Market
Seeking Alpha
Sat, 09/8/12 - 10:38 am
Vivus
Qsymia
weight loss
obesity
Arena And Vivus Set To Dominate The Obesity Drug Market
Seeking Alpha
Thu, 08/30/12 - 09:58 am
Arena
Vivus
obesity
Belviq
Qsymia
3 Reasons to Sell: VIVUS
Motley Fool
Thu, 08/23/12 - 09:54 am
Vivus
patents
Qsymia
Now That Vivus Was Downgraded, Where Should Investors Turn?
Seeking Alpha
Mon, 08/20/12 - 11:45 am
Vivus
investors
obesity
Qsymia
3 Drug Companies That Want to Lose
Motley Fool
Sun, 08/19/12 - 11:32 am
Arena
Vivus
Orexigen
obesity
weight loss
Belviq
Qsymia
Contrave
Empatic
Healthcare Biz Recap: Vivus’ PATENT Problem, Idenix Survives Clinical HOLD
Wall Street Cheat Street
Sat, 08/18/12 - 03:48 pm
Vivus
generics
Qsymia
Idenix
Pluristem Therapeutics
Vivus Falls after Downgrade
Barron's
Sat, 08/18/12 - 03:33 pm
Vivus
Qsymia
generics
Vivus Bulls: A Chance To Get In At $15.80 Or Earn An Extra 18.8%
Seeking Alpha
Sat, 08/18/12 - 03:32 pm
Vivus

Pages